返回 Agenda
Session Chair(s)
Xiaojun GUO, PHD
Head
GlaxoSmith-Kline, China
Speaker(s)
Dan Wang
CFDA- Wuxi FDA, China
Minzhu Li
Postmarketing Safety Expert, China
Postmarketing Safety Expert
Gang Cheng
CFDA, China
Assistant Director, National Center for ADR Monitor
Jingping Mo, MD, PHD
Pfizer Inc., United States
Director
Dayou WANG
Huashan Hospital, Fudan University, China
Lei Sun
GlaxoSmithKline(China) Investment Co., Ltd., China
Associate Clinical Research Manager